Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Successful therapy of herpes hominis keratitis in rabbits by 5-10D0-5'-amino-2'5'-dideoxyuridine (AIU): a novel analog of thymidine

Journal Article · · Invest. Ophthalmol.; (United States)
OSTI ID:6433733

The efficiency of 5-iodo-5'-amino-2'5'-dideoxyuridine (AIU) in the therapy of experimental herpes keratitis in rabbits has been examined. Virus infections were established bilaterally in 40 animals using herpes simplex, type 1 (NIH strain 11124). Twenty-four hours after infection the rabbits were divided into five matched groups of eight and each group was treated, double-blind, with topical drugs at four-hour intervals for a total of 72 hours. The solutions instilled were: saline; IdUrd, 1 mg. per milliliter); AIU, 1 mg. per milliliter; AIU, 4 mg. per milliliter; and AIU, 8 mg. per milliliter. Each eye was examined daily for 12 days and graded independently by two ophthalmologists. Although IdUrd and AIU (8 mg. per milliliter were effective therapeutically, IdUrd had a greater effect. The AIU at 1 and 4 mg. per milliliter were less active, but showed more rapid healing than the saline control. Viral recovery studies are consistent with the clinical observations. A second independent experiment, similar to that described above, gave essentially identical results. Although less potent than IdUrd, AIU does providee effective therapy for herpes keratitis.

Research Organization:
Yale Univ., New Haven, CT
OSTI ID:
6433733
Journal Information:
Invest. Ophthalmol.; (United States), Journal Name: Invest. Ophthalmol.; (United States) Vol. 15:6; ISSN INOPA
Country of Publication:
United States
Language:
English